Skip to main content
. 2024 Jun 19;14(6):726. doi: 10.3390/biom14060726

Figure 7.

Figure 7

Necrosulfonamide (NSA) treatment reduces the serum levels of interleukin (IL)-1β and IL-18 in experimental abdominal aortic aneurysms. Twenty-eight days after angiotensin II infusion, sera were prepared from differentially treated apolipoprotein E-deficient mice. Serum levels of IL-1β (A) and IL-18 (B) were assessed via enzyme-linked immunosorbent assay. All data are mean ± standard deviation. Student’s t test, * p < 0.05 compared to vehicle treatment.